Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

NCT01485861 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

298

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Abiraterone
DRUG: Apitolisib
DRUG: Ipatasertib
DRUG: Placebo
DRUG: Prednisone
DRUG: Prednisolone

Sponsor

Genentech, Inc.